In a dose-escalation study of DNX-2401 in patients with newly diagnosed DMG, it was found in tumour tissue from patients that immune cell infiltration of CD4+ and CD8+ T cells was scarce while CD11b+ myeloid cells were the most abundant immune population upon diagnosis [15]. Here, CD8A is linked to neoplasm.